Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: Cancer. 2016 Nov 7;123(6):977–984. doi: 10.1002/cncr.30415

Figure 5. Serum sVCAM-1 concentration.

Figure 5

Levels of sVCAM-1 were determined from serum of ovarian cancer patients undergoing PDS (light blue squares) or NACT (dark blue triangles) taken just prior to each chemotherapy session (sequences 1–6) and during 3 follow-up visits. VCAM-1 concentration was determined from serum withdrawn from women free of disease at 4 monthly intervals (control, red circles).